Mammalian lignans and genistein decrease the activities of aromatase and 17β-hydroxysteroid dehydrogenase in MCF-7 cells

Journal of Steroid Biochemistry and Molecular Biology

Volumn 94, Issue 5, 2005, Pages 461-467

  Brooks, Jennifer D ^a   Thompson, Lilian U ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

17 Hydroxysteroid dehydrogenase; Aromatase; Isoflavones; Lignans; MCF 7; Phytoestrogens

Indexed keywords

AROMATASE; ENTERODIOL; ENTEROLACTONE; ESTRADIOL; ESTRONE; FORMESTANE; GENISTEIN; ISOFLAVONE; LIGNAN; TESTOSTERONE 17BETA DEHYDROGENASE;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL PROLIFERATION; CELL STRAIN MCF 7; ENZYME ACTIVITY; ENZYME INHIBITION; HORMONE SYNTHESIS; HUMAN; HUMAN CELL; NONHUMAN;

17-HYDROXYSTEROID DEHYDROGENASES; 4-BUTYROLACTONE; ANIMALS; AROMATASE; AROMATASE INHIBITORS; BREAST NEOPLASMS; CELL LINE, TUMOR; ESTRADIOL; FEMALE; GENISTEIN; HUMANS; LIGNANS; MAMMALS; PHYTOESTROGENS;

MAMMALIA; MINK CELL FOCUS-FORMING VIRUS;

EID: 18144386167     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jsbmb.2005.02.002     Document Type: Article

References (50)

1. H. Adlercreutz Phytestrogens and breast cancer J. Steroid Biochem. Mol. Biol. 83 1-5 2002 113 118
2. L. Thompson Flaxseed, lignans and cancer LU. Thompson SC. Cunnane Flaxseed in Human Nutrition 2003 AOCS Press Champaign, IL
3. J. Pasqualini, G. Chetrite, and E. Le Nestour Control and expression of oestrone sulphatase activities in human breast cancer J. Endocrinol. 150 1996 S99 S105
4. C. Jefcoate, J. Liehr, R. Santen, T. Sutter, J. Yager, W. Yue, S. Santner, R. Tekmal, L. Demers, R. Pauley, F. Naftolin, G. Mor, and L. Bernstein Tissue specific synthesis and oxidative metabolism of estrogens J. Natl. Cancer Inst. Monogr. 27 2000 95 111
5. J. Pasqualini, and G. Chetrite Paradoxical effect of estradiol: it can block its own biotransformation in human breast cancer cells J. Steroid Biochem. Mol. Biol. 78 1 2001 21 24
6. G. Chetrite, and J. Pasqualini The selective estrogen enzyme modulator (SEEM) in breast cancer J. Steroid Biochem. Mol. Biol. 76 2001 95 104
7. C. Kirk, R. Harris, D. Wood, R. Waring, and P. Hughes Do dietary phytoestrogens influence susceptibility to hormone dependent cancer by disrupting the metabolism of endogenous oestrogens? Biochem. Soc. Trans. 29 2 2001 209 216
8. E. Perel, D. Wilkins, and D. Killinger The conversion of androstenedione to estrone, estradiol and testosterone in breast tissue J. Steroid Biochem. 13 1 1980 89 94
9. M. Poutanen, V. Isomaa, V. Lehto, and R. Vihko Immunological analysis of 17β-hydroxysteroid dehydrogenase in benign and malignant human breast tissue Int. J. Cancer 50 1992 386 390
10. A. Brodie, Q. Lu, and J. Nakamura Aromatase in the normal breast and breast cancer J. Steroid Biochem. Mol. Biol. 61 3-6 1997 281 286
11. A. Brodie, Q. Lu, B. Long, A. Fulton, T. Chen, N. Macpherson, P. DeJong, M. Blankenstein, J. Nortier, P. Slee, J. van de Ven, J. van Gorp, J. Elbers, M. Schipper, G. Blijham, and J. Thijssen Aromatase and COX-2 expression in human breast cancers J. Steroid Biochem. Mol. Biol. 79 1-5 2001 41 47
12. E. Thompson, and P. Siiteri Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatizatoin of androstenedione J. Biol. Chem. 249 17 1974 5364 5372
13. C. Gunnarsson, B. Olsson, O. Stål Members of the Southeast Sweden Breast Cancer Group Abnormal expression of 17β-hydroxysteroid dehydrogenase in breast cancer predicts late recurrence Cancer Res. 61 2001 8448 8451
14. C. Gunnarsson, M. Ahnström, K. Kirschner, B. Olsson, B. Nordenskjold, L. Rutqvist, L. Skoog, and O. Stal Amplification of HSD17B1 and ERBB2 in primary breast cancer Oncogene 22 2003 34 40
15. J. Pasqualini, G. Chetrite, C. Blacker, M. Teinstein, L. Delalonde, M. Talbi, and C. Maloche Concentrations of estrone, estradiol and estrone sulfate and evaluation of sulfatase and aromatase activities in pre- and post-menopausal breast cancer patients J. Clin. Endocrinol. Metab. 81 4 1996 1460 1464
16. W. Yue, L. Berstein, J. Wang, G. Clarke, C. Hamilton, L. Demers, and R. Santen The potential role of estrogen in aromatase regulation in the breast J. Steroid Biochem. Mol. Biol. 79 2001 157 164
17. K. Li, R. Smith, and Z. Krozowski Cloning and expression of a novel tissue specific 17beta-hydroxysteroid dehydrogenase Endocr. Res. 24 3-4 1998 663 667
18. J. Pasqualini, G. Chetrite, B. Nguyen, C. Maloche, L. Delalonde, M. Talbi, M. Feinstein, C. Blacker, J. Botella, and J. Paris Estrone sulfate-sulfatase and 17β-hydroxysteroid dehydrogenase activities: a hypothesis for their role in the evolution of human breast cancer from hormone-dependent to hormone independent J. Steroid Biochem. Mol. Biol. 53 1-6 1995 407 412
19. M. Blankenstein, J. van de Ven, I. Maitimu-Smeele, G. Donker, P. Chr de Jong, J. Daroszeski, J. Szymczak, A. Milewicz, and J. Thijssen Intratumoral levels of estrogens in breast cancer J. Steroid Biochem. Mol. Biol. 69 1999 293 297
20. J. Bonneterre, A. Buzdar, J-M. Nabholtz, J. Robertson, B. Thürlimann, M. von Euler, T. Sahmoud, A. Webster, M. Steinberg For the Arimidex Writing Committee on behalf of the Investigators Committee Members Anastrazole is superior to tamoxifen as first-line therapy in hormone receptor positive advanced breast carcinoma. Results of two randomized trials designed for combined analysis Cancer 92 2001 2247 2258
21. C. Wang, T. Mäkelä, T. Hase, H. Adlercreutz, and M. Kurzer Lignans and flavonoids inhibit aromatase enzyme in human preadipocytes J. Steroid Biochem. Mol. Biol. 50 3-4 1994 205 212
22. H. Adlercreutz, C. Bannwart, K. Wähälä, T. Makela, G. Brunow, T. Hase, P. Arosemena, J. Kellis Jr., and L. Vickery Inhibition of human aromatase by mammalian lignans and isoflavonoid phytoestrogens J. Steroid Biochem. Mol. Biol. 44 2 1993 147 153
23. J. Le Bail, Y. Champaveir, A. Chulia, and G. Habrioux Effects of phytoestrogens on aromatase, 3β and 17β-hydroxysteroid dehydrogenase activities in human breast cancer cells Life Sci. 66 14 2000 1281 1291
24. B. Evans, K. Griffiths, and M. Morton Inhibition of 5α-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids J. Endocrinol. 147 1995 295 302
25. S. Whitehead, J. Cross, C. Burden, and M. Lacey Acute and chronic effects of genistein, tryphostin and lavendustin A on steroid synthesis in luteinized human granulosa cells Hum. Reprod. 17 3 2002 589 594
26. D. Campbell, and M. Kurzer Flavonoid inhibition of aromatase enzyme activity in human preadipocytes J. Steroid Biochem. Mol. Biol. 46 3 1993 381 388
27. K. Almstrup, M. Fernández, J. Petersen, N. Olea, N. Skakkebæk, and H. Leffers Dual effects of phytoestrogens results in a U-shaped dose-response curves Environ. Health Perspect. 110 8 2002 743 748
28. R. Brueggemeier, X. Gu, J. Mobley, S. Joomprabutra, A. Bhat, and J. Whetstone Effects of phytoestrogens and synthetic combinatorial libraries on aromatase, estrogen biosynthesis, and metabolism Ann. N.Y. Acad. Sci. 948 2001 51 66
29. S. Mäkelä, M. Poutanen, J. Lehtimäki, M.-L. Kostian, R. Santti, and R. Vihko Estrogen-specific 17β-hydroxysteroid oxidoreductase type 1 (E.C. 1.1.1.62) as a possible target for the action of phytoestrogens Proc. Soc. Exp. Biol. Med. 208 1995 51 59
30. W. Burak, A. Quinn, W. Farrar, and R. Brueggemeier Androgens influence estrogen-induced responses in human breast carcinoma cells through cytochrome P450 aromatase Breast Cancer Res. Treat. 44 1997 57 64
31. T. Yanase, Y. Mu, K. Goto, M. Nomura, T. Okabe, R. Takayanagi, and H. Nawata Regulation of aromatase by nuclear receptors J. Steroid Biochem. Mol. Biol. 79 2001 187 192
32. M. Poutanen, V. Isomaa, H. Peltoket, and R. Vihko Role of 17 beta-hydroxysteroid dehydrogenase type 1 in endocrine and introcrine estradiol biosynthesis J. Steroid Biochem. Mol. Biol. 55 5-6 1995 525 532
33. N. Harada, T. Motsumoto, N. Yoshimura, H. Sakamoto, and S. Honda Analysis of transcriptional regulation of human breast aromatase by in vitro and in vivo studies J. Steroid Biochem. Mol. Biol. 79 2001 151 156
34. W. Mazur, and H. Adlercreutz Overview of naturally occurring endocrine-active substances in the human diet in relation to human health Nutrition 16 7-8 2000 654 658
35. D. Hargreaves, C. Potten, C. Harding, L. Shaw, M. Morton, S. Roberts, A. Howell, and N. Bundred Two-week dietary soy supplementation has an estrogenic effect on normal premenopausal breast J. Clin. Endocrinol. Metab. 84 1999 4017 4024
36. M. Morton, P. Chan, C. Cheng, N. Blacklock, A. Matos-Ferreira, L. Abranches-Monteiro, R. Correia, S. Lloyd, and K. Griffiths Lignans and isoflavonoids in plasma and prostatic fluid in men: samples from Portugal, Hong Kong and the United Kingdom Prostate 32 1997 122 128
37. Y. Mousavi, and H. Adlercreutz Enterolactone and estradiol inhibit each other's proliferative effect on MCF-7 breast cancer cells in culture J. Steroid Biochem. Mol. Biol. 41 3-8 1992 615 619
38. L. Devoto, M. Vega, O. Castro, and P. Kohen Effect of the aromatase inhibitor 4-OHA on progesterone synthesis by human luteal cells Fertil. Steril. 55 1991 922 926
39. B. Grube, E. Eng, Y-C. Kao, A. Kwon, and S. Chen White button mushroom phytochemicals inhibit aromatase activity and breast cancer cell proliferation J. Nutr. 131 2001 3288 3293
40. P. Jellinck, S. Lee, and B. McEwen Metabolism of dehydroepiandrosterone by rat hippocampal cells in culture: possible role of aromatization and 7-hydroxylation in neuroprotection J. Steroid Biochem. Mol. Biol. 78 2001 313 317
41. M. Bradford A rapid sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein dye binding Anal. Biochem. 72 1976 248 254
42. M. Pagliacci, M. Smacchia, G. Migliorati, F. Grignani, C. Riccardi, and I. Nicoletti Growth-inhibitory effects of the natural phyto-oestrogen genistein in MCF-7 human breast cancer cells Eur. J. Cancer 30 1994 1675 1682
43. A. Constantinou, N. Kamath, and J. Murley Genistein inactivates bcl-2, delays the G2/M phase of the cell cycle, and induces apoptosis of human breast adenocarcinoma MCF-7 cells Eur. J. Cancer 34 1998 1927 1934
44. 2+-mediated, calpain/caspase-12-dependent apoptosis in breast cancer cells Biochem. Biophys. Res. Commun. 321 2004 462 467
45. B. Long, S. Tilghman, W. Yue, A. Thiantanawat, D. Grigoryev, and A. Brodie The steroidal antiestrogen ICI 182, 780 is an inhibitor of cellular aromatase activity J. Steroid Biochem. Mol. Biol. 67 4 1998 293 304
46. J. Le Bail, C. Pouget, C. Fagnere, J. Basly, A. Chulia, and G. Habrioux Chalcones are potent inhibitors of aromatase and 17β-hydroxysteroid dehydrogenase activities Life Sci. 68 2001 751 761
47. Y. Kinoshita, and S. Chen Induction of aromatase (CYP19) expression in breast cancer cells through a nongenomic action of estrogen receptor α Cancer Res. 63 2003 3546 3555
48. J. Richards, T. Petrel, and R. Brueggemeier Signaling pathway regulating aromatase and cyclooxygenases in normal and malignant breast cells J. Steroid Biochem. Mol. Biol. 80 2002 203 212
49. L. Berstein, H. Zheng, W. Yue, J-P. Wang, A. Lykkesfeldt, F. Naftolin, N. Harada, M. Shanabrough, and R. Santen New approaches to the understanding of tamoxifen action and resistance Endocr. Relat. Cancer 10 2003 267 277
50. A. Singh, and M. Reed Insulin-like growth factor type I and insulin-like growth factor type II stimulate oestradiol-17β hydroxysteroid dehydrogenase (reductive) activity in breast cancer cells J. Endocrinol. 129 1991 5 8